Integrin-linked kinase and its uses
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- SUNNYBROOK HEALTH SCI CENT
- Publication Date
- 2007-08-30
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a a continuation of U.S. patent application Ser. No. 09 / 967,854, filed Sep. 28, 2001, which is a Divisional of U.S. patent application Ser. No. 09 / 390,425, filed Sep. 3, 1999, which is a Continuation of U.S. patent application Ser. No. 09 / 035,706, filed Mar. 5, 1998, now issued as U.S. Pat. No. 6,001,622 on Dec. 14, 1999, which is a continuation-in-part of U.S. patent application Ser. No. 08 / 955,841, filed Oct. 21, 1997, now issued as U.S. Pat. No. 6,013,782 on Jan. 11, 2000, which is a continuation-in-part of U.S. patent application Ser. No. 08 / 752,345, filed Nov. 19, 1996, now abandoned which claims priority to provisional patent application No. 60 / 009,074, filed Dec. 21, 1995.INTRODUCTION
[0002] 1. Background
[0003] Proteins of the extracellular matrix (ECM) act to influence fundamental cell and tissue behaviors. ECM regulates cell structure, growth, survival, differentiation, motility and, at the organismal level...